Skip to main content
SpringerLink
Log in

Base the short-term use of ibuprofen in infants aged 3–6 months on body weight and administer via the oral route if possible

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Ibuprofen is the NSAID most commonly used to treat mild-moderate pain, fever and inflammation in children, although dosage recommendations in infants aged 3–6 months still differ between countries. Based on the available evidence, the short-term use of ibuprofen to manage pain and fever appears to be effective and safe in infants aged 3–6 months who weigh ≥ 5–6 kg. The dosage should be weight-based, with preference given to oral preparations. To minimize the risk of renal toxicity, it is important to ensure than the infant is adequately hydrated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. de Martino M, Chiarugi A, Boner A, et al. Working towards an appropriate use of ibuprofen in children: an evidence-based appraisal. Drugs. 2017;77(12):1295–311.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ziesenitz VC, Zutter A, Erb TO, et al. Efficacy and safety of ibuprofen in infants aged between 3 and 6 months. Paediatr Drugs. 2017;19(4):277–90.

    Article  PubMed  Google Scholar 

  3. Adis Medical Writers. Consider pharmacological treatment to close patent ductus arteriosus in preterm infants when the condition is haematologically significant. Drugs Ther Perspect. 2017;33(1):22–5.

    Article  Google Scholar 

  4. Kauffman RE, Nelson MV. Effect of age on ibuprofen pharmacokinetics and antipyretic response. J Pediatr. 1992;121(6):969–73.

    Article  CAS  PubMed  Google Scholar 

  5. Kyllonen M, Olkkola KT, Seppala T, et al. Perioperative pharmacokinetics of ibuprofen enantiomers after rectal administration. Paediatr Anaesth. 2005;15(7):566–73.

    Article  PubMed  Google Scholar 

  6. Vilenchik R, Berkovitch M, Jossifoff A, et al. Oral versus rectal ibuprofen in healthy volunteers. J Popul Ther Clin. 2012;19(2):e179–86.

    Google Scholar 

  7. Brown RD, Wilson JT, Kearns GL, et al. Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children. J Clin Pharmacol. 1992;32(3):231–41.

    Article  CAS  PubMed  Google Scholar 

  8. Simila S, Kouvalainen K, Keinanen S. Oral antipyretic therapy. Scand J Rheumatol. 1976;5(2):81–3.

    Article  CAS  PubMed  Google Scholar 

  9. Wilson G, Guerra AJ, Santos NT. Comparative study of the antipyretic effect of ibuprofen (oral suspension) and paracetamol (suppositories) in paediatrics. J Int Med Res. 1984;12(4):250–4.

    Article  CAS  PubMed  Google Scholar 

  10. Yue Z, Jiang P, Sun H, et al. Association between an excess risk of acute kidney injury and concomitant use of ibuprofen and acetaminophen in children, retrospective analysis of a spontaneous reporting system. Eur J Clin Pharmacol. 2014;70(4):479–82.

    Article  CAS  PubMed  Google Scholar 

  11. Lesko SM, Mitchell AA. The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics. 1999;104(4):e39.

    Article  CAS  PubMed  Google Scholar 

  12. Ashraf E, Ford L, Geetha R, Cooper S. Safety profile of ibuprofen suspension in young children. Inflammopharmacology. 1999;7(3):219–25.

    Article  CAS  PubMed  Google Scholar 

  13. Joshi YM, Sovani VB, Joshi VV, et al. Comparative evaluation of the antipyretic efficacy of ibuprofen and paracetamol. Indian Pediatr. 1990;27(8):803–6.

    CAS  PubMed  Google Scholar 

  14. Romsing J, Walther-Larsen S. Peri-operative use of nonsteroidal anti-inflammatory drugs in children: analgesic efficacy and bleeding. Anaesthesia. 1997;52(7):673–83.

    Article  CAS  PubMed  Google Scholar 

  15. Maunuksela EL, Ryhanen P, Janhunen L. Efficacy of rectal ibuprofen in controlling postoperative pain in children. Can J Anaesth. 1992;39(3):226–30.

    Article  CAS  PubMed  Google Scholar 

  16. Kokki H, Hendolin H, Maunuksela EL, et al. Ibuprofen in the treatment of postoperative pain in small children: a randomized double-blind-placebo controlled parallel group study. Acta Anaesthesiol Scand. 1994;38(5):467–72.

    Article  CAS  PubMed  Google Scholar 

  17. Pfaff JA, Hsu K, Chennupati SK. The use of ibuprofen in posttonsillectomy analgesia and its effect on posttonsillectomy hemorrhage rate. Otolaryngol Head Neck Surg. 2016;155(3):508–13.

    Article  PubMed  Google Scholar 

  18. Summary review for regulatory action. Caldolor injection/ibuprofen intravenous injection (NDA 22348, Supplement 005). Silver Spring: US Food and Drug Administration; 2015.

    Google Scholar 

  19. Clark E, Plint AC, Correll R, et al. A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics. 2007;119(3):460–7.

    Article  PubMed  Google Scholar 

  20. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen: a practitioner-based randomized clinical trial. JAMA. 1995;273(12):929–33.

    Article  CAS  PubMed  Google Scholar 

  21. Hadas D, Youngster I, Cohen A, et al. Premarketing surveillance of ibuprofen suppositories in febrile children. Clin Pediatr. 2011;50(3):196–9.

    Article  Google Scholar 

  22. Balestracci A, Ezquer M, Elmo ME, et al. Ibuprofen-associated acute kidney injury in dehydrated children with acute gastroenteritis. Pediatr Nephrol. 2015;30:1873–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

    Consortia

    Adis Medical Writers

    Ethics declarations

    Conflict of interest

    The article was adapted from Pediatric Drugs 2017;19(4):277–20 [2] by employees of Adis/Springer, who are responsible for the article content and declare no conflicts of interest.

    Funding

    The preparation of this review was not supported by any external funding.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Adis Medical Writers. Base the short-term use of ibuprofen in infants aged 3–6 months on body weight and administer via the oral route if possible. Drugs Ther Perspect 34, 207–211 (2018). https://doi.org/10.1007/s40267-018-0487-1

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40267-018-0487-1

    Search

    Navigation